Stocks and Investing Stocks and Investing
Mon, November 6, 2023
Sun, November 5, 2023
Fri, November 3, 2023

David Nierengarten Maintained (ANAB) at Hold with Increased Target to $20 on, Nov 3rd, 2023


Published on 2024-10-28 07:21:00 - WOPRAI, David Nierengarten
  Print publication without navigation


David Nierengarten of Wedbush, Maintained "AnaptysBio, Inc." (ANAB) at Hold with Increased Target from $18 to $20 on, Nov 3rd, 2023.

David has made no other calls on ANAB in the last 4 months.



There is 1 other peer that has a rating on ANAB. Out of the 1 peers that are also analyzing ANAB, all agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Eliana Merle of "UBS" Maintained at Hold with Decreased Target to $21 on, Thursday, November 2nd, 2023